Treatment of Wernicke-Korsakoff Syndrome in Chronic Alcohol Use Disorder

Immediate Thiamine Administration Protocol

The American College of Physicians recommends that all patients with chronic alcohol use disorder undergoing withdrawal or presenting with neurological symptoms must receive immediate high-dose parenteral thiamine before any glucose-containing fluids, with a treatment regimen of 500 mg IV three times daily for 3-5 days for suspected or confirmed Wernicke's encephalopathy 1, 2
Every patient undergoing alcohol withdrawal requires prophylactic thiamine 100-300 mg/day to prevent Wernicke's encephalopathy, maintained for 2-3 months after withdrawal resolution, as recommended by the Clinical and Molecular Hepatology guidelines 3, 1

Thiamine must always be administered before any glucose-containing IV fluids, as glucose can precipitate or worsen acute thiamine deficiency and trigger Wernicke's encephalopathy, according to the Clinical and Molecular Hepatology guidelines 3, 4, 1, 2

Administer 500 mg thiamine IV three times daily for 3-5 days, followed by 250 mg IV daily for at least 3-5 additional days, as recommended by the Praxis Medical Insights guidelines 1, 2
For established Wernicke's encephalopathy requiring extended treatment, use 100-500 mg/day for 12-24 weeks, according to the Clinical and Molecular Hepatology guidelines 4, 1

After parenteral treatment, transition to oral thiamine 50-100 mg daily, as recommended by the Praxis Medical Insights guidelines 2
Continue oral supplementation long-term as patients with alcohol use disorder commonly have ongoing nutritional deficiencies, according to the Clinical and Molecular Hepatology guidelines 3

Do not wait for laboratory confirmation before initiating treatment - thiamine is safe and delay worsens outcomes, as recommended by the Praxis Medical Insights guidelines 2
Do not assume hepatic encephalopathy explains all cognitive symptoms - Wernicke's encephalopathy frequently coexists with hepatic encephalopathy in alcoholic liver disease and must be considered separately, according to the Liver International guidelines 5, 2

Benzodiazepines are the gold standard for alcohol withdrawal syndrome treatment, according to the Clinical and Molecular Hepatology guidelines 3, 6, 7
Long-acting benzodiazepines (chlordiazepoxide 25-100 mg every 4-6 hours, or diazepam 5-10 mg every 6-8 hours) are preferred for seizure prevention, as recommended by the Clinical and Molecular Hepatology guidelines 3, 4
Lorazepam 1-4 mg every 4-8 hours is recommended for patients with liver failure, advanced age, or respiratory failure, according to the Clinical and Molecular Hepatology guidelines 3, 4

Alcohol abstinence is mandatory to prevent extension of neural damage and is the most important long-term treatment, as recommended by the Clinical and Molecular Hepatology guidelines 4
Psychiatric consultation is recommended for evaluation, acute management, and long-term abstinence planning, according to the Clinical and Molecular Hepatology guidelines 3
Consider pharmacological support for abstinence maintenance with acamprosate, naltrexone, or baclofen after acute phase, as recommended by the Clinical and Molecular Hepatology guidelines 4, 6